Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
procedures as required, and fulfills additional assigned duties as needed. QUALIFICATIONS (Education & Experience): Minimum Qualifications: This position requires a PhD from an accredited institution with
-
is in the Morsani College of Medicine and houses graduate level programs in Biomedical Sciences. The MD-PhD Program at the University of South Florida is a combined degree program that integrates
-
service functions within the college and the university. Salary and benefits are highly competitive, depending on experience and qualifications. QUALIFICATIONS: Minimum Qualifications: PhD required in
-
website at http://health.usf.edu/index.html POSITION SUMMARY: The Department of Family Medicine at the University of South Florida, Morsani College of Medicine is seeking a PhD Psychologist with experience
-
appropriate experience and training within a selected area of specialization. Must meet university criteria for appointment to the rank of Postdoctoral Fellow. Preferred Qualifications: PhD in Neuroscience
-
for appointment to the rank of Postdoctoral Fellow. PREFERRED: PhD or equivalent in Data Science, Bioinformatics, AI/ML, Biomedical engineering, or related discipline. Previous postdoctoral experience is not
-
completed terminal degree in music (PhD, DMA, etc.). The candidate must document prior experience teaching applied percussion lessons at the post-secondary level, administrating a college/university
-
majors -- PhD, MS in Computer Science, and MS in Computer Engineering. RESPONSIBILITIES: Identify barrier breakers for the in-need students serve as a counselor to these students. Track students
-
of Postdoctoral Fellow. Preferred Qualifications: • Ph.D. or MD/PhD. with experience in micro-surgery is highly desirable. • Research experience in RNAseq, proteomics, primary cell culture
-
at http://health.usf.edu/index.html. POSITION SUMMARY: An experienced, Master's level researcher (PhD is preferred) is needed to support the development of a novel cancer immunotherapy program in